Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xalacom vs Xalatan vs Timolol in Glaucoma/OHT
NCT00159653Phase 3Completed
- Sponsor
- Viatris
- Start
- Jul 2005
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial of timolol in open-angle glaucoma (OAG) and ocular hypertension (3 arms), sponsored by Viatris. Primary endpoint: Intraocular Pressure at 12 weeks. Started Jul 2005; status: completed.
02
Drugs
timolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00159653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00159653.